Contributions of innate type 2 inflammation to adipose function
- PMID: 29891508
- PMCID: PMC6795076
- DOI: 10.1194/jlr.R085993
Contributions of innate type 2 inflammation to adipose function
Abstract
A critical contributor to the health consequences of the obesity epidemic is dysregulated adipose tissue (AT) homeostasis. While white, brown, and beige AT function is altered in obesity-related disease, white AT is marked by progressive inflammation and adipocyte dysfunction and has been the focus of extensive "immunometabolism" research in the past decade. The exact triggering events initiating and sustaining AT inflammation are still under study, but it has been shown that reducing inflammation improves insulin action in AT. Scientific efforts seeking interventions to mitigate obesity-associated AT inflammation continue, and many groups are now determining how lean healthy AT homeostasis is maintained in order to leverage these mechanisms as therapeutic targets. Such studies have revealed that an elaborate network of immune cells, cytokines, and other cellular mediators coordinate AT function. Recent studies elucidated the involvement of the innate immune system in AT homeostasis (e.g., beiging and insulin sensitivity), including M2-like macrophages, eosinophils, innate lymphoid type 2 cells, and several others. In this review, we summarize the existing literature on innate type 2 inflammation in AT; additionally, we draw attention to areas of debate where seemingly conflicting data promises to yield more surprising and elegant biology as studies continue to dissect AT physiology.
Keywords: adipose tissue; beiging; eosinophil; homeostasis; innate immune system; innate lymphoid type 2 cell; macrophage; obesity.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
EoTHINophils: Eosinophils as key players in adipose tissue homeostasis.Clin Exp Pharmacol Physiol. 2020 Aug;47(8):1495-1505. doi: 10.1111/1440-1681.13304. Epub 2020 Mar 24. Clin Exp Pharmacol Physiol. 2020. PMID: 32163614 Review.
-
Innate immune cells in the adipose tissue.Rev Endocr Metab Disord. 2018 Dec;19(4):283-292. doi: 10.1007/s11154-018-9451-6. Rev Endocr Metab Disord. 2018. PMID: 29922964 Review.
-
Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity.Nature. 2015 Mar 12;519(7542):242-6. doi: 10.1038/nature14115. Epub 2014 Dec 22. Nature. 2015. PMID: 25533952 Free PMC article.
-
The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation.Eur J Immunol. 2015 Sep;45(9):2446-56. doi: 10.1002/eji.201545502. Epub 2015 Aug 19. Eur J Immunol. 2015. PMID: 26220361 Review.
-
Regulation of metabolic health and adipose tissue function by group 2 innate lymphoid cells.Eur J Immunol. 2016 Jun;46(6):1315-25. doi: 10.1002/eji.201545562. Epub 2016 May 17. Eur J Immunol. 2016. PMID: 27120716 Free PMC article. Review.
Cited by
-
Extrinsic and Intrinsic Immunometabolism Converge: Perspectives on Future Research and Therapeutic Development for Obesity.Curr Obes Rep. 2019 Sep;8(3):210-219. doi: 10.1007/s13679-019-00344-2. Curr Obes Rep. 2019. PMID: 30919312 Free PMC article. Review.
-
Metabolic Inflammation and Insulin Resistance in Obesity.Circ Res. 2020 May 22;126(11):1549-1564. doi: 10.1161/CIRCRESAHA.119.315896. Epub 2020 May 21. Circ Res. 2020. PMID: 32437299 Free PMC article. Review.
-
Peripheral Administration of NMU Promotes White Adipose Tissue Beiging and Improves Glucose Tolerance.Int J Endocrinol. 2021 Aug 2;2021:6142096. doi: 10.1155/2021/6142096. eCollection 2021. Int J Endocrinol. 2021. PMID: 34422045 Free PMC article.
-
Intermittent fasting for the prevention of cardiovascular disease.Cochrane Database Syst Rev. 2021 Jan 29;1(1):CD013496. doi: 10.1002/14651858.CD013496.pub2. Cochrane Database Syst Rev. 2021. PMID: 33512717 Free PMC article.
-
Kynurenic acid as the neglected ingredient of commercial baby formulas.Sci Rep. 2019 Apr 15;9(1):6108. doi: 10.1038/s41598-019-42646-4. Sci Rep. 2019. PMID: 30988385 Free PMC article.
References
-
- Centers for Disease Control and Prevention. 2016. Behavioral Risk Factor Surveillance System. Accessed October 1, 2017, at http://www.cdc.gov/obesity/data/prevalence-maps.html.
-
- Flegal K. M., Carroll M. D., Kit B. K., and Ogden C. L.. 2012. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 307: 491–497. - PubMed
-
- Ogden C. L., Carroll M. D., Fryar C. D., and Flegal K. M.. 2015. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief. 219: 1–8. - PubMed
-
- Shoelson S. E., Herrero L., and Naaz A.. 2007. Obesity, inflammation, and insulin resistance. Gastroenterology. 132: 2169–2180. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous